Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Barrett, Matthew J.a; * | Koeppel, Alexander F.b | Flanigan, Joseph L.a | Turner, Stephen D.b | Worrall, Bradford B.a; c
Affiliations: [a] Department of Neurology, University of Virginia, Charlottesville, VA, USA | [b] Bioinformatics Core, University of Virginia School of Medicine, Charlottesville, VA, USA | [c] Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA
Correspondence: [*] Correspondence to: Matthew J. Barrett, MD, MSc, University of Virginia, Department of Neurology, P.O. Box 800394, Charlottesville, VA 22908, USA. Tel.: +1434 243 2012; E-mail: [email protected].
Abstract: Background: Meta-analysis of genome-wide association studies have implicated multiple single nucleotide polymorphisms (SNPs) and associated genes with Alzheimer disease. The role of these SNPs in cognitive impairment in Parkinson disease (PD) remains incompletely evaluated. Objective: The objective of this study was to test alleles associated with risk of Alzheimer disease for association with cognitive impairment in Parkinson disease (PD). Methods: Two datasets with PD subjects accessed through the NIH database of Genotypes and Phenotypes contained both single nucleotide polymorphism (SNP) arrays and mini-mental state exam (MMSE) scores. Genetic data underwent rigorous quality control and we selected SNPs for genes associated with AD other than APOE. We constructed logistic regression and ordinal regression models, adjusted for sex, age at MMSE, and duration of PD, to assess the association between selected SNPs and MMSE score. Results: In one dataset, PICALM rs3851179 was associated with cognitive impairment (MMSE < 24) in PD subjects > 70 years old (OR = 2.3; adjusted p-value = 0.017; n = 250) but not in PD subjects≤70 years old. Conclusions: Our finding suggests that PICALM rs3851179 could contribute to cognitive impairment in older patients with PD. It is important that future studies consider the interaction of age and genetic risk factors in the development of cognitive impairment in PD.
Keywords: Parkinson disease, mild cognitive impairment, dementia, Alzheimer disease, genetics
DOI: 10.3233/JPD-150706
Journal: Journal of Parkinson's Disease, vol. 6, no. 1, pp. 119-124, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]